Related Experiment Video
Updated: May 31, 2026

Modeling Mitochondrial Disease Using Brain Organoids: A Focus on Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episodes
Published on: October 10, 2025
Distinct distal myopathy phenotype caused by VCP gene mutation in a Finnish family
Johanna Palmio1, Satu Sandell, Tiina Suominen
1Neuromuscular Research Unit, Department of Neurology, University Hospital and University of Tampere, Finland. johanna.palmio@uta.fi
Abstract:
Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD) is caused by mutations in the valosin-containing protein (VCP) gene. We report a new distal phenotype caused by VCP gene mutation in a Finnish family with nine affected members in three generations. Patients had onset of distal leg muscle weakness and atrophy in the anterior compartment muscles after age 35, which caused a foot drop at age 50. None of the siblings had scapular winging, proximal myopathy, cardiomyopathy or respiratory problems during long-term follow-up. Three distal myopathy patients developed rapidly progressive dementia, became bedridden and died of cachexia and pneumonia and VCP gene mutation P137L (c.410C>T) was then identified in the family. Late onset autosomal dominant distal myopathy with rimmed vacuolar muscle pathology was not sufficient for exact diagnosis in this family until late-occurring dementia provided the clue for molecular diagnosis. VCP needs to be considered in the differential diagnostic work-up in patients with distal myopathy phenotype.
Insights
Mutations in the valosin-containing protein (VCP) gene cause a rare distal myopathy. This VCP gene mutation presents with leg weakness and can lead to dementia, requiring consideration in differential diagnoses.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD) is linked to mutations in the valosin-containing protein (VCP) gene.
- The VCP gene's role in neuromuscular and neurodegenerative disorders is increasingly recognized.
Purpose of the Study:
- To report a novel distal phenotype associated with VCP gene mutations in a Finnish family.
- To highlight the diagnostic challenges and clues for identifying VCP-related myopathies.
Main Methods:
- Clinical evaluation of nine affected family members across three generations.
- Phenotypic analysis including muscle weakness, atrophy, and neurological progression.
- Genetic analysis to identify the specific VCP gene mutation (P137L, c.410C>T).
Main Results:
- A distinct distal myopathy phenotype characterized by adult-onset anterior compartment leg muscle weakness and foot drop was observed.
- Affected individuals did not exhibit proximal myopathy, scapular winging, or cardiac/respiratory issues.
- A subset of patients developed rapidly progressive dementia, cachexia, and pneumonia, leading to mortality.
- The P137L mutation in the VCP gene was identified as the causative genetic factor.
Conclusions:
- VCP gene mutations can manifest as a late-onset autosomal dominant distal myopathy with unique clinical features.
- The presence of dementia is a critical diagnostic clue for VCP-related disorders, even in the absence of typical IBMPFD symptoms.
- VCP should be considered in the differential diagnosis of patients presenting with distal myopathy, particularly when accompanied by neurological decline.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pleiotropy
Huntington Disease l: Introduction
Sex-linked Disorders
Single Nucleotide Polymorphisms-SNPs

